Nick Macklon

Nov 28, 2024 | rbmojournal.com | Balsam Al Hashimi |Simon Harvey |Katie Harvey |Elena Linara-Demakakou |Darren Griffin |Kamal Ahuja | +1 more

KeywordsDICSIin vitro maturationmaternal ageoocytepoor prognosisIntroductionControlled ovarian hyperstimulation for in vitro fertilisation (IVF) treatment aims to safely stimulate the growth of multiple ovarian follicles to allow the retrieval of mature, competent oocytes that have progressed to the metaphase II (MII) stage of meiosis that culminates in the extrusion of the first polar body.

Oct 11, 2024 | rbmojournal.com | Kamal Ahuja |Giuseppina Lamanna |Nick Macklon

Key wordssurrogacyoocyte vitrificationtransgender familiesdonor spermcryostorageGet full text accessLog in, subscribe or purchase for full access. BiographyKamal Ahuja: After completing his PhD in embryology studies at the University of Cambridge with Professor Sir Robert Edwards, Kamal Ahuja moved to London to head the Cromwell Hospital IVF Programme as its founding Scientific Director, where he remained for over 20 years.

Oct 5, 2024 | rbmojournal.com | Nick Macklon |Juan Garcia Velasco

Those of us fortunate enough to work in the field of reproductive medicine are familiar with the media interest in our work which can be sometimes hostile and sometimes celebratory. Since the early days of IVF, the near universal profound wish to conceive a family has driven deep interest in almost every turn of advancement in the field. The pace of scientific progress has been remarkable and not infrequently a source of controversy.

Jul 17, 2024 | rbmojournal.com | Anna McLaughlin |Nick Macklon |Elena Linara-Demakakou

AbstractWhat were the clinical outcomes from 332 autologous vitrified- warmed oocyte cycles derived from 3182 elective autologous oocyte freeze cycles carried out between 2008 and 2022 in a single-centre series? In this retrospective observational study, outcomes in 299 patients returning to use their frozen oocytes between 2015 and 2023 were analysed. A total of 3328 elective oocyte vitrification cycles were performed in 2280 patients. The return rate to use oocytes was 14% (299/2171).

Jan 31, 2024 | rbmojournal.com | Nick Macklon |Juan Garcia-Velasco |Kamal Ahuja

As the New Year starts and we mark one year working together as Chief Editors and Chair of Reproductive Health Care Ltd it seems an apposite moment to reflect on the changes that we have introduced in this time. In short, the journal is flourishing. Much credit for this goes to our predecessors, especially the previous Chief Editors, Jacques Cohen and Bart Fauser. Their vision, and that of the journal founders, set a course for RBMO that we are privileged to continue.